These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8523398)

  • 41. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats.
    van Heek M; Farley C; Compton DS; Hoos LM; Smith-Torhan A; Davis HR
    Br J Pharmacol; 2003 Apr; 138(8):1459-64. PubMed ID: 12721101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effect.
    Karaki F; Ohgane K; Dodo K; Hashimoto Y
    Bioorg Med Chem; 2013 Sep; 21(17):5297-309. PubMed ID: 23830695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agents.
    Augelli-Szafran CE; Blankley CJ; Roth BD; Trivedi BK; Bousley RF; Essenburg AD; Hamelehle KL; Krause BR; Stanfield RL
    J Med Chem; 1993 Oct; 36(20):2943-9. PubMed ID: 8411011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antimicrobial activity of 1-(p-substituted)phenyl-3-(p-alkoxy)phenyl-4-phenyl-azetidin-2-ones.
    Diurno MV; Cristinziano A; Mazzoni O; Piscopo E; Bolognese A
    Farmaco; 1995 Feb; 50(2):143-8. PubMed ID: 7766278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.
    van Heek M; Farley C; Compton DS; Hoos L; Davis HR
    Br J Pharmacol; 2001 Sep; 134(2):409-17. PubMed ID: 11564660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
    Chhajed SS; Upasani CD
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):504-8. PubMed ID: 21823835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroidomimetic aminomethyl spiroacetals as novel inhibitors of the enzyme Δ8,7-sterol isomerase in cholesterol biosynthesis.
    Krojer M; Müller C; Bracher F
    Arch Pharm (Weinheim); 2014 Feb; 347(2):108-22. PubMed ID: 24493593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
    Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H
    Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity.
    Clader JW; Berger JG; Burrier RE; Davis HR; Domalski M; Dugar S; Kogan TP; Salisbury B; Vaccaro W
    J Med Chem; 1995 May; 38(10):1600-7. PubMed ID: 7752185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 53. Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Harris NV; Smith C; Ashton MJ; Bridge AW; Bush RC; Coffee EC; Dron DI; Harper MF; Lythgoe DJ; Newton CG
    J Med Chem; 1992 Nov; 35(23):4384-92. PubMed ID: 1447739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.
    Mulchande J; Guedes RC; Tsang WY; Page MI; Moreira R; Iley J
    J Med Chem; 2008 Mar; 51(6):1783-90. PubMed ID: 18290604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor.
    Fung AK; Baker WR; Fakhoury S; Stein HH; Cohen J; Donner BG; Garvey DS; Spina KP; Rosenberg SH
    J Med Chem; 1997 Jul; 40(14):2123-5. PubMed ID: 9216829
    [No Abstract]   [Full Text] [Related]  

  • 56. Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors.
    Galletti P; Quintavalla A; Ventrici C; Giannini G; Cabri W; Penco S; Gallo G; Vincenti S; Giacomini D
    ChemMedChem; 2009 Dec; 4(12):1991-2001. PubMed ID: 19821480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and antihyperlipidemic evaluation of novel 2-[1-(substitutedphenyl)-4-oxo-azetidin-2-yl]-5,6-disubstitutedthieno[2,3-d]pyrimidin-4(3H)-ones.
    Arya N; Munde MK; Dwivedi J; Jagdale AY; Jain KS
    Arch Pharm (Weinheim); 2013 Aug; 346(8):588-95. PubMed ID: 23881664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N/C-4 substituted azetidin-2-ones: synthesis and preliminary evaluation as new class of antimicrobial agents.
    Halve AK; Bhadauria D; Dubey R
    Bioorg Med Chem Lett; 2007 Jan; 17(2):341-5. PubMed ID: 17098426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.
    Roughley SD; Browne H; Macias AT; Benwell K; Brooks T; D'Alessandro J; Daniels Z; Dugdale S; Francis G; Gibbons B; Hart T; Haymes T; Kennett G; Lightowler S; Matassova N; Mansell H; Merrett A; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Simmonite H; Tan K; Walls SB; Wong M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):901-6. PubMed ID: 22209458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines.
    Kumura K; Wakiyama Y; Ueda K; Umemura E; Watanabe T; Shitara E; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2016 Jun; 69(6):440-5. PubMed ID: 26758495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.